Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02355210 · ClinicalTrials.gov registry record · NA
Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults
A NA study of Intestinal Microbiota and Barrier Function, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
- 1
- Study location
NCT02355210 is a NA study of Intestinal Microbiota and Barrier Function that has completed, run by Rush University Medical Center. The registered enrollment target is 151 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02355210, a NA study of Intestinal Microbiota and Barrier Function, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effect of a dietary supplement to improve gut health. The participants will take one of six dietary treatments for three weeks, and the gut bacteria and the gut intestinal barrier will be assessed to determine if these dietary treatments beneficially change these markers of gut health.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Bifidobacteria adolescentis BD1
- DIETARY_SUPPLEMENT Bifidobacteria animalis subsp. lactis BB-12
- DIETARY_SUPPLEMENT Bifidobacteria adolescentis BD1 and galactooligosaccharide
- DIETARY_SUPPLEMENT Bifidobacteria animalis subsp. lactis BB-12 and galactooligosaccharide
- DIETARY_SUPPLEMENT galactooligosaccharide
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02355210
The ClinicalTrials.gov registry entry for NCT02355210 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intestinal Microbiota and Barrier Function appearing as the primary indexed condition, and to 5 interventions - of which Bifidobacteria adolescentis BD1 is the first listed.
NCT02355210 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02355210 about?
NCT02355210 is a clinical study titled "Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults". This study evaluates the effect of a dietary supplement to improve gut health. The participants will take one of six dietary treatments for three weeks, and the gut bacteria and the gut intestinal barrier will be assessed to determine if these dietary treatments beneficially change these markers of ...
What is the current status of trial NCT02355210?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2013-06. Estimated completion is 2015-10.
What conditions does trial NCT02355210 study?
This clinical trial studies the following conditions: Intestinal Microbiota and Barrier Function.
What interventions are being tested in trial NCT02355210?
The interventions under investigation include: Bifidobacteria adolescentis BD1 (DIETARY_SUPPLEMENT), Bifidobacteria animalis subsp. lactis BB-12 (DIETARY_SUPPLEMENT), Bifidobacteria adolescentis BD1 and galactooligosaccharide (DIETARY_SUPPLEMENT), Bifidobacteria animalis subsp. lactis BB-12 and galactooligosaccharide (DIETARY_SUPPLEMENT), galactooligosaccharide (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02355210?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02355210 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.